INTEGRA LIFESCIENCES HOLDINGS CORP
Integra LifeSciences Holdings Corporation (NASDAQ: IART) is a global medical technology company dedicated to restoring lives through transformational care and impactful innovation. The company manufactures and sells medical technologies and products across two reportable business segments: Codman Specialty Surgical… From the company’s description.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What INTEGRA LIFESCIENCES HOLDINGS CORP does
In the company’s own words
Integra LifeSciences Holdings Corporation (NASDAQ: IART) is a global medical technology company dedicated to restoring lives through transformational care and impactful innovation. The company manufactures and sells medical technologies and products across two reportable business segments: Codman Specialty Surgical (CSS), which represents approximately 70 percent of total revenue, and Tissue Technologies (TT), which generates about 30 percent of overall revenue. The company's website is www.integralifesciences.com.
The CSS segment consists of market-leading technologies and instrumentation used across neurosurgery, neurocritical care, and otolaryngology (ear, nose, and throat). Integra holds the position of world leader in neurosurgery and ranks among the top three providers in the United States for precision, specialty, and general surgical instruments. Key CSS products include the CUSA ultrasonic surgical aspirator platform, CereLink intracranial pressure monitoring systems, DuraGen and DuraSeal dural repair products, Mayfield cranial stabilization systems, and the TruDi navigation system for ENT procedures.
The TT segment focuses on wound reconstruction and care and private label manufacturing, utilizing five unique regenerative technology platforms based on bovine collagen, bovine dermis, porcine urinary bladder matrix, human amniotic tissue, and resorbable synthetic mesh. Principal TT products include Integra Skin bilayer matrix for burn treatment, PriMatrix dermal repair scaffold, SurgiMend collagen matrix for hernia repair, and MediHoney wound dressings. The company was the first to receive FDA approval for dermal tissue regeneration claims.
Integra operates key manufacturing and research facilities across multiple U.S. states including California, Maryland, Massachusetts, New Jersey, Ohio, Puerto Rico, Tennessee, and Utah, as well as internationally in France, Germany, Ireland, Israel, and Switzerland. The company maintains a global commercial network of direct sales representatives and independent distributors serving hospitals, integrated health networks, surgery centers, and healthcare providers worldwide. The company did not have any customers representing more than 10 percent of consolidated revenues in 2025. Integra's competitive advantages include its depth and breadth of sales and marketing organization, innovative technology platforms, and established procurement and manufacturing operations.
Company details
- Sector
- Healthcare
- Industry
- Surgical & Medical Instruments
- Headquarters
- PRINCETON, NJ
- Fiscal year end
- December
- CIK
- 917520
- SIC
- 3841
Financial performance, year by year
Fiscal 2013–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns INTEGRA LIFESCIENCES HOLDINGS CORP — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · INTEGRA LIFESCIENCES HOLDINGS CORP’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do INTEGRA LIFESCIENCES HOLDINGS CORP and its peers compare on margins and cash generation over ten years?”
- “Where did five years of INTEGRA LIFESCIENCES HOLDINGS CORP's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in INTEGRA LIFESCIENCES HOLDINGS CORP's last four quarterly filings that the numbers alone won't show?”